To elucidate the impact of elevated levels of CCR1, CXCL12, CCR2, and CCR4 on the effectiveness of ICIs in the treatment of lung cancer, the TIDE algorithm was employed for predictive purposes. This evidence concerns the gene CXCL12 and lung carcinoma.